The drug can offer people with early multiple sclerosis many more years free from worsening disability, and Oxford played an important role in the drug's development.
Oxford's part in a new multiple sclerosis drug
- 18 September 2013
- Research
- Innovation
A highly effective new treatment for multiple sclerosis was approved yesterday by the European Medicines Agency, the regulator for drugs in Europe.